---
source_pdf: "https://drive.google.com/file/d/1W-HXOtV08l3AGG1qBEP6rUZj5nt3dkS1/view"
drive_folder: "Research"
type: research

ingested: 2025-12-28
original_filename: "Chamber.pdf"
---

> **Original:** [View Original PDF](https://drive.google.com/file/d/1W-HXOtV08l3AGG1qBEP6rUZj5nt3dkS1/view)

## Slide 1: Investor Presentation - September 2023

CVD ~$400B
Annual Spend

CHAMBER
CARDIO

Investor Presentation
September 2023

chambercardio.com

## Slide 2: OUR MISSION

**Improved Cardiovascular Health for All**

Our mission is to empower cardiology teams to operate in a value-based world, ensuring that providers are compensated for delivering the right care at the right time.

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 3: CHAMBERCARDIO

Your Trusted Partner in Value-Based Cardiovascular Care

*   **60+ Network Providers**
*   **1 University Health System Partnership**
*   **125K+ Patients** Cared for by Our Network
*   **2 VBC Agreements**

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 4: THE OPPORTUNITY

**Cardiovascular Disease Is the Costliest Condition To Treat**
$400 Billion spent annually on cardiovascular disease

*   **$1 out of every $6** healthcare dollars spent

**Annual Spend Trend**
| Year | Spend (Billion USD) |
| :--- | :------------------ |
| 2023 | $400                 |
| 2028 | $550                 |

*   **5% expected annual increase to $550B by 2028**

**Avoidable Spend**
*   **30% considered avoidable** (Represents 30% of total spend in a pie chart)

## Slide 5: THE OPPORTUNITY

**Cardiovascular Disease Places a Heavy Burden on All Americans and the Health System**

*   **1 out of 5** deaths due to heart disease
*   **2x incidence of CVD deaths** in adults with low socio-economic status
*   **25% 30-Day readmission rate** for CHF
*   **6.4** Average number of inpatient days (CHF)
*   **30% inappropriate Invasive procedures**
*   **1.2M discharges and ER visits** annually for CHF

## Slide 6: THE PROBLEM

**The Current System Leaves All Stakeholders Frustrated**

**Cardiologists**
*   Compensated for quantity over quality of care
*   Inability to negotiate with payers

**Health Plans**
*   Minimal alignment with cardiology practices
*   Rising costs for preventable and unnecessary care

**Primary Care Providers**
*   Difficulty identifying high performing cardiologists
*   Communication gaps with cardiologists

**Patients**
*   Lack of comprehensive cardiology care
*   Fragmented care among all providers

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 7: THE SOLUTION

**Chamber Solves This Problem by Acting as the Heart of the Cardiology Care Ecosystem**

*   **Cardiologists**
*   **Health Plans**
*   **Primary Care Providers**
*   **Patients**

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 8: THE SOLUTION

**Chamber Is Uniquely Positioned To Take On This Role**

**Team**
*   Health Plan Experience
*   Clinical Expertise

**Network**
*   Community-Based
*   High-Performing

**Care Model**
*   Evidence-Based Practices
*   Outcomes Driven

**Product**
*   Real-Time Insights
*   Action-Oriented Tools

## Slide 9: THE TEAM

**Chamber Leadership**

**George Aloth**
Co-Founder & CEO
George is a healthcare operations and business executive with 15+ years of experience. He has served previously as Group President at Somatus, a value-based kidney care leader, President & CEO of a BCBS health plan and COO at a Medicaid/Medicare payer. He also sits on the Board of Directors at George Washington University Hospital.

**Sameer Sheth, MD**
Co-Founder & President/CMO
Dr. Sheth is a board-certified cardiologist practicing at Mass General Hospital, a Harvard Medical School affiliate. He was a clinical leader at CareMore, RubiconMD & Oak Street Health. He graduated from Yale School of Medicine, completed his residency at Brigham and Women's Hospital, and fellowship at Mount Sinai Hospital.

**Scott Keim**
Chief Growth Officer
Scott is an experienced healthcare executive. He last served as CGO at P3 Health Partners, where he had oversight of national payer relationships and ACO REACH strategy. He also served as Head of Network Innovation and Business Development at Aetna CVS Health and has held executive roles at UnitedHealth Group and PacifiCare.

**Andrew Dilling**
Head of Product
Andrew is an experienced product leader with a passion for leveraging technology to improve people's health and wellbeing. With 16+ years in product management, he has a proven track record of bringing innovative products to market. Prior to joining Chamber, Andrew led product initiatives at AppNexus, Flatiron Health and Olive AI.

**Ahna Millat**
Chief of Staff
Ahna is an experienced healthcare operations leader. She has 10+ years of experience working on both the payer side, including a BCBS health plan, and on the health system side. She has overseen various areas including, health plan operations, project management, vendor oversight and strategy & development.

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 10: THE TEAM

**Board of Directors**
Chamber Cardio is backed by Alley Corp, a leading early-stage venture fund and incubator that founds and funds transformative healthcare companies

**Jeffrey De Flavio, MD**
Board Chairman
Jeffrey De Flavio, MD is a Partner and Entrepreneur-in-Residence at AlleyCorp. He is the co-founder and Chairman of Pearl Health and was previously the founding CEO of Groups Recover Together. Dr. De Flavio's expertise is in value-based care, clinical redesign and early-stage growth.

**Kevin Ryan**
Board Member
Often called the "Godfather of NYC tech," Kevin Ryan is one of the leading internet entrepreneurs and investors in a New York. He is a co-founder of MongoDB, Business Insider, Gilt Groupe, Zola and Nomad Health, and founds new companies with AlleyCorp every year.

**George Aloth**
Board Member
George is a healthcare operations and business executive with 15+ years of experience. He has served previously as Group President at Somatus, a value-based kidney care leader, President & CEO of a BCBS health plan and COO at a Medicaid/Medicare payer. He also sits on the Board of Directors at George Washington University Hospital.

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 11: THE TEAM

**Advisors**

**Gabriel Drapos**
Advisor
Gabriel, COO and founding team member at Pearl Health, is a former leader at Centivo and early employee at Oscar Health. He has held various roles, including Product Operations, Chief of Staff, Interim Head of Marketing and a Special Projects role on the Data Analytics team. He graduated with an A.B. in Philosophy from Harvard University.

**Brenton Fargnoli, MD**
Advisor
Dr. Fargnoli is Managing Partner at AlleyCorp Healthcare and previously worked at Flatiron Health, J.P. Morgan and BlueCross & BlueShield. Board-certified in Internal Medicine, Dr. Fargnoli previously practiced at Memorial Sloan Kettering and completed residency at Harvard's Brigham and Women's Hospital.

**Rishi Wadhera, MD**
Advisor
Dr. Wadhera is Section Head of Health Policy & Equity at Smith Center for Outcomes Research, cardiologist at Beth Israel Deaconess Medical Center, and Assist. Professor of Medicine at Harvard Medical School. He is also an adjunct Professor of Health Policy & Management at Harvard School of Public Health.

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 12: THE NETWORK

**Chamber's Early Success Recruiting Cardiologists**

*   **64 Network Providers Caring for ~125,000 Patients**
*   **1 Large University Health System** (GW Medical Faculty Associates)
*   **65 Providers Currently in Advanced Conversations**

(Map shows coverage in Washington D.C., Maryland, and Virginia)

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 13: THE CARE MODEL

**Transforming Cardiology Care**

*   **Linked To Outcomes**
    *   Improving admissions, ER visits and quality of life
*   **Powered by Technology**
    *   Enhancing the provider and patient experience with actionable insights
*   **Equitable and Scalable**
    *   Supporting screening tools and workflows providing quality care for all
*   **Evidence-Based Clinical Care**
    *   Bringing the latest clinical trials into practice

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 14: THE CARE MODEL

**Improving All Aspects of Cardiovascular Health Through Prevention and Longitudinal Disease Management**

These 5 conditions are responsible for around 75% of cardiovascular spending

*   **Hypertension**
*   **Hyperlipidemia**
*   **Coronary Artery Disease**
*   **Atrial Fibrillation**
*   **Congestive Heart Failure**

## Slide 15: THE CARE MODEL

**Our Tech-Enabled Network Delivers Care Across All Stages**

**Risk Prediction** (Timeline point 1)
*   **Stage A**
    *   Risk Prediction/ Stratification
    *   Comorbidity Management
    *   Primary Care Engagement
    *   Multidisciplinary Care Teams

**Care Team** (Timeline point 2)
*   **Stage B**
    *   Clinical Pathways
    *   Virtual Visits
    *   Remote Patient Monitoring

**Cardiology Program** (Timeline point 3)
*   **Stage C**
    *   Goal Directed Medical Therapy
    *   Post-Discharge Pathways

**Outcomes Measurement** (Timeline point 4)
*   **Stage D**
    *   Goals of Care

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 16: THE CARE MODEL

**Chamber Provides Our Network Support To Help Fill In the Gaps**

**Medical Director**
*   Responsible for clinical pathway development
*   Reviews care plans
*   Drives patient goals and care

**Practice Liaison**
*   Point of contact for payers
*   Point of contact for network cardiologists
*   Coordination of IT infrastructure, data needs

**Care Coordination Services**
*   Patient scheduling, reminders, and education
*   Referrals to community resources
*   Coordinate between network cardiologists and PCPs/specialists

**Pharmacy Services**
*   Medication review
*   Medication adherence education
*   Coordination with local pharmacies

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 17: THE PRODUCT

**Chamber's Technology Will Enable Practices To Succeed in Value-Based Care**

**Seamless Integration (Data & Software)**
*   Ease, speed and reliability of data interoperability
*   Embedded user experience (within existing workflows & and preferred applications)
*   Real-time insights & notifications
*   Task management and communication across care team members

**Tech-Enabled Clinical Care Delivery**
*   Evidence-based clinical guidelines and medication management
*   Care gap discovery and closure recommendations
*   Automated risk assessments for all chronic cardiovascular diseases

**Comprehensive Reporting & Analytics**
*   Monitor practice and provider performance and quality against benchmarks
*   Identify trends in care delivery and health outcomes across patient population
*   Real-time insight into VBC reimbursement and financial metrics

## Slide 18: THE PRODUCT

**Chamber's Tech Empowers Cardiologists With Customized Insights About Their Panel**

**Dashboard Overview Highlights:**
*   **Review notifications, tasks and communicate with care team** (Arrow pointing to top right notification/tasks section)
*   **High-level panel insights with real-time risk scores** (Arrow pointing to "Patients by Risk Status" section)
    *   **High Risk:** 23 patients
    *   **Moderate Risk:** 31 patients
    *   **Low Risk:** 16 patients
    *   **Unknown Risk:** 14 patients
    *   **Risk Status (by Primary Dx):**
        *   Congestive Heart Failure (36 patients): High(18), Moderate(9), Low(3), Unknown(6)
        *   Cardiac Arrhythmia / Atrial Fibrillation (15 patients): High(2), Moderate(5), Low(4), Unknown(4)
        *   Coronary Artery Disease (12 patients): High(2), Moderate(5), Low(4), Unknown(1)
        *   Other Cardiovascular Disease (21 patients): High(4), Moderate(6), Low(6), Unknown(5)
    *   **Elevated Risk (last 30 days):**
        *   Carson Cartwright (4 days ago, Moderate -> High)
        *   Brant Skiles (6 days ago, Unknown -> High)
        *   Riley Bergstrom (7 days ago, Low -> Moderate)
    *   **Downgraded Risk (last 30 days):**
        *   Brooks Prohaska (2 days ago, High -> Moderate)
        *   Jackelyn Klocko (6 days ago, Moderate -> Low)
        *   Jamaal Klein (8 days ago, High -> Moderate)
*   **Clinical Pathway Enrollment** (Arrow pointing to "Clinical Pathway Enrollment" section, which is not fully visible, but implied by the context of risk status)
*   **Current status of patients in ER, Hospital or Discharged** (Arrow pointing to "Hospital Encounters" section)
    *   Emergency Room (active): 1 patient (since last week)
    *   Inpatient Admission (active): 12 patients (since last week)
    *   Recently Discharged (last 72 hours): 0 patients (since last week)
    *   Post-Discharge (within 90 days of discharge): 31 patients (since last week)
*   **Highlighting upcoming appointments and pending clinical tasks** (Arrow pointing to "Upcoming Patient Visits" section)
    *   **Today (1 visit)**
        *   Pending Sep 14, 2023: Carson Cartwright, Coronary Artery Disease, High
    *   **Tomorrow (1 visit)**
        *   Proposed Sep 15, 2023: Neoma Hickle, Congestive Heart Failure, High
    *   **Upcoming Week (2 visits)**
        *   Booked Sep 21, 2023: Brant Skiles, Hypertension, High
        *   Pending Sep 21, 2023: Jamaal Klein, Congestive Heart Failure, Low
    *   **Next 30 Days (8 visits)**
        *   Booked Sep 24, 2023: Kelly Schillers, Congestive Heart Failure, High
        *   Pending Sep 25, 2023: Jason Goodwin, Coronary Artery Disease, Low
        *   Pending Sep 26, 2023: Shardas Hodkiewicz, Congestive Heart Failure, High
        *   Booked Sep 30, 2023: Neoma Hickle, Congestive Heart Failure, High

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 19: GO TO MARKET

**Chamber Is Actively Growing Its Payer Pipeline**

**Initial Meetings**
*   United Healthcare
*   Elevance Health
*   MOLINA HEALTHCARE
*   Cigna
*   Humana.

**Ongoing Diligence**
*   MedStar Family Choice
*   AmeriHealth.
*   aetna
*   Amerigroup

**Signed LOI**
*   CareFirst (CareFirst BlueCross BlueShield logo)

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 20: GO TO MARKET

**Chamber Is Also Participating in New ACO Models**

*   Cardiologists act as PCPs for chronic conditions like Heart Failure and Coronary Artery Disease
*   Allow cardiologists to learn about value-based care with shared savings upside and no downside risk
*   Voluntary alignment as a way for practices to grow

**Initial Meetings**
*   Aledade
*   cityblock
*   PRIVIA HEALTH

**Signed Contract**
*   pearl

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 21: GO TO MARKET

**Strategic Expansion Based on Patient Population and Independent Cardiologists**

**TEXAS**
*   4.6M Medicare eligibles, 52% MA penetration (UHG #1, 1.2M members)
*   5.7M Medicaid eligibles (approx. 50% enrolled in comprehensive MCOs)
*   Compelling opportunity with large cardio group in Houston
*   350+ independent cardiologists

**PENNSYLVANIA**
*   2.9M Medicare eligibles, 51% MA penetration (Aetna #1, 396k members)
*   3.5M Medicaid eligibles
*   Adjacency with initial markets
*   280+ independent cardiologists

**OHIO**
*   2.5M Medicare eligibles, 54% MA penetration (Elevance #1, 1.3M members)
*   3.2M Medicaid eligibles
*   Prevalence of RBEs taking MLR risk on MA
*   Adjacency with initial markets
*   200+ independent cardiologists

**NORTH CAROLINA**
*   2.1M Medicare eligibles, 53% MA penetration (HUM #1, 407k members)
*   2M Medicaid eligibles
*   Adjacency with initial markets
*   160+ independent cardiologists

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 22: FINANCE

**Sample Payer Contract Unit Economics**

| Category                       | Value (PMPY) | Description                                       |
| :----------------------------- | :----------- | :------------------------------------------------ |
| Medicare Advantage:            | $47,249      |                                                   |
| D-SNP:                         | $70,872      |                                                   |
| Medicaid:                      | $18,040      |                                                   |
| Commercial:                    | $20,365      |                                                   |
| **Average Annual TCOC**        | **$41,244**  | Blended TCOC*                                     |
| Targeted Saving of 5%          | $2,062       |                                                   |
| **Chamber Gross Revenue**      | **$1,031**   | 50% SPLIT OF SAVINGS WITH PAYER                   |
| Enhanced Care Coordination Fee | $96          |                                                   |
| **Total Chamber Annual Revenue per Member** | **$1,127**   |                                                   |

*Assumes a blend of 70% MA, 5% D-SNP, 20% Medicaid, 5% Commercial

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 23: FINANCE

**5 Year P&L Forecast**

*   Negotiating for enhanced monthly care coordination fees
*   Expected risk corridors and reinsurance through Payer to limit exposure
*   Core investments in national cardiology network and technology platform

| ($M)                          | 2024E   | 2025E     | 2026E     | 2027E     | 2028E     |
| :---------------------------- | :------ | :-------- | :-------- | :-------- | :-------- |
| At-Risk Lives                 | 6,000   | 28,000    | 75,600    | 144,000   | 242,000   |
| MSUM                          | $247.5  | $1,154.8  | $3,118.0  | $5,939.1  | $9,981.0  |
| **Revenues (Gross)**          | **$4.4** | **$21.7**  | **$62.0**  | **$126.8** | **$231.0** |
| Advance Payments              | $0.6    | $2.8      | $7.5      | $13.9     | $23.2     |
| Accrued Shared Savings        | $3.8    | $18.9     | $54.5     | $112.9    | $207.8    |
| **Cost of Care**              | **$2.8** | **$12.5**  | **$33.8**  | **$67.2**  | **$119.0** |
| Care Delivery                 | $0.7    | $3.5      | $9.2      | $17.3     | $29.2     |
| Provider Incentives           | $1.3    | $6.5      | $18.8     | $39.5     | $72.7     |
| Technology                    | $0.4    | $0.8      | $1.3      | $1.8      | $2.6      |
| Reinsurance                   | $0.4    | $1.7      | $4.5      | $8.6      | $14.5     |
| **Gross Margin**              | **$1.6** | **$9.3**  | **$28.1**  | **$59.5**  | **$112.1** |
| Gross Margin %                | 36%     | 43%       | 45%       | 47%       | 49%       |
| **Operating Expenses**        | **$5.6** | **$9.6**  | **$18.9**  | **$29.4**  | **$48.0**  |
| General & Administrative      | $5.1    | $8.6      | $17.0      | $25.8     | $41.1     |
| Other Corp. Costs             | $0.5    | $1.0      | $1.9      | $3.6      | $6.9      |
| **EBITDA**                    | **$(4.0)**| **$(0.3)** | **$9.3**  | **$30.1**  | **$64.1**  |
| EBITDA Margin %               | -91%    | -1%       | 15%       | 24%       | 28%       |

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 24: FINANCE

**Key Metrics**

**Total Markets**
| Year | Markets |
| :--- | :------ |
| 2024 | 2       |
| 2025 | 6       |
| 2026 | 12      |
| 2027 | 20      |
| 2028 | 30      |

**Total Cardiologists**
| Year | Cardiologists |
| :--- | :------------ |
| 2024 | 60            |
| 2025 | 200           |
| 2026 | 420           |
| 2027 | 720           |
| 2028 | 1,100         |

**Total VBC Lives**
| Year | VBC Lives (K) |
| :--- | :------------ |
| 2024 | 6             |
| 2025 | 28            |
| 2026 | 75            |
| 2027 | 144           |
| 2028 | 242           |

**Savings Generated**
| Year | Savings Generated (M USD) |
| :--- | :------------------------ |
| 2024 | $7                        |
| 2025 | $37                       |
| 2026 | $107                      |
| 2027 | $226                      |
| 2028 | $416                      |

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 25: FINANCE

**Funding Overview and Use of Proceeds**

**SEPTEMBER 2022: Initial Investment**
*   Top-Tier Founding Team: Leaders across Operations, Clinical, Product and Sales
*   Built Large Cardiology Network Across DC, Maryland and Virginia
*   2 VBC Agreements

**SEPTEMBER 2023: Funding**
*   Invest In Product to Accelerate Technology Enablement of Network
*   Key Strategic Hires: Engineering, Finance, Data Science and Legal/Compliance
*   Market Expansion and Business Development

**2024: Post-Funding**
*   12 Markets
*   420+ Cardiologists
*   8 Payer Deals
*   Robust Technology Platform for Comprehensive Cardiology Value-Based Care

Chamber Cardio | Private and Confidential | Investor Presentation - 2023

## Slide 26: THANK YOU

THANK YOU

CHAMBER
CARDIO

chambercardio.com